310 related articles for article (PubMed ID: 33159093)
1. Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy.
George B; Lumen A; Nguyen C; Wesley B; Wang J; Beitz J; Crentsil V
NPJ Syst Biol Appl; 2020 Nov; 6(1):36. PubMed ID: 33159093
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models.
Abduljalil K; Ning J; Pansari A; Pan X; Jamei M
Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066
[TBL] [Abstract][Full Text] [Related]
3. Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach.
Van Der Heijden JEM; Van Hove H; Van Elst NM; Van Den Broek P; Van Drongelen J; Scheepers HCJ; De Wildt SN; Greupink R
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38763343
[TBL] [Abstract][Full Text] [Related]
4. Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after delivery.
Dallmann A; Himstedt A; Solodenko J; Ince I; Hempel G; Eissing T
J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):341-359. PubMed ID: 32748112
[TBL] [Abstract][Full Text] [Related]
5. Physiologically-Based Pharmacokinetic Model of Sertraline in Human to Predict Clinical Relevance of Concentrations at Target Tissues.
Alhadab AA; Brundage RC
Clin Pharmacol Ther; 2020 Jul; 108(1):136-144. PubMed ID: 32128758
[TBL] [Abstract][Full Text] [Related]
6. A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.
De Sousa Mendes M; Lui G; Zheng Y; Pressiat C; Hirt D; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Urien S; Benaboud S
Clin Pharmacokinet; 2017 May; 56(5):537-550. PubMed ID: 27766562
[TBL] [Abstract][Full Text] [Related]
7. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
Zhang Z; Unadkat JD
Drug Metab Dispos; 2017 Aug; 45(8):939-946. PubMed ID: 28049636
[TBL] [Abstract][Full Text] [Related]
8. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
[TBL] [Abstract][Full Text] [Related]
9. Predicting fetal exposure of crizotinib during pregnancy: Combining human ex vivo placenta perfusion data with physiologically-based pharmacokinetic modeling.
Roelofsen D; van Hove H; Bukkems V; Russel F; Eliesen G; Greupink R
Toxicol In Vitro; 2022 Dec; 85():105471. PubMed ID: 36096459
[TBL] [Abstract][Full Text] [Related]
10. The application of precision dosing in the use of sertraline throughout pregnancy for poor and ultrarapid metabolizer CYP 2C19 subjects: A virtual clinical trial pharmacokinetics study.
Almurjan A; Macfarlane H; Badhan RKS
Biopharm Drug Dispos; 2021 Jun; 42(6):252-262. PubMed ID: 33851424
[TBL] [Abstract][Full Text] [Related]
11. Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini-review on availability and limitations.
Berezowska M; Sharma P; Pilla Reddy V; Coppola P
Fundam Clin Pharmacol; 2024 Jun; 38(3):402-409. PubMed ID: 37968879
[TBL] [Abstract][Full Text] [Related]
12. Quantification of sertraline maternal/fetal ratio and amniotic fluid concentration using a pregnancy physiologically based pharmacokinetic model.
Lartey D; Jateng D; Li M; Nguyen C; Crentsil V; Beitz J; George B
Br J Clin Pharmacol; 2023 Jun; ():. PubMed ID: 37312614
[TBL] [Abstract][Full Text] [Related]
13. Drug dosing during pregnancy-opportunities for physiologically based pharmacokinetic models.
Abduljalil K; Badhan RKS
J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):319-340. PubMed ID: 32592111
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach.
Abduljalil K; Pansari A; Ning J; Jamei M
Clin Pharmacokinet; 2022 May; 61(5):725-748. PubMed ID: 35067869
[TBL] [Abstract][Full Text] [Related]
15. Prediction of maternal and fetal pharmacokinetics of indomethacin in pregnancy.
Pillai VC; Shah M; Rytting E; Nanovskaya TN; Wang X; Clark SM; Ahmed MS; Hankins GDV; Caritis SN; Venkataramanan R
Br J Clin Pharmacol; 2022 Jan; 88(1):271-281. PubMed ID: 34185331
[TBL] [Abstract][Full Text] [Related]
16. An Application of a Physiologically Based Pharmacokinetic Approach to Predict Ceftazidime Pharmacokinetics in a Pregnant Population.
Abduljalil K; Gardner I; Jamei M
Pharmaceutics; 2024 Mar; 16(4):. PubMed ID: 38675135
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants and Antipsychotics in Human Pregnancy: Transfer Across the Placenta and Opportunities for Modeling Studies.
Zheng L; Yang H; Dallmann A
J Clin Pharmacol; 2022 Sep; 62 Suppl 1():S115-S128. PubMed ID: 36106784
[TBL] [Abstract][Full Text] [Related]
18. Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir.
Liu XI; Momper JD; Rakhmanina N; van den Anker JN; Green DJ; Burckart GJ; Best BM; Mirochnick M; Capparelli EV; Dallmann A
J Clin Pharmacol; 2020 Feb; 60(2):240-255. PubMed ID: 31489678
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating Ex Vivo Placental Perfusion Data and Physiologically-Based Pharmacokinetic Modeling.
Freriksen JJM; Schalkwijk S; Colbers AP; Abduljalil K; Russel FGM; Burger DM; Greupink R
Clin Pharmacol Ther; 2020 Jun; 107(6):1352-1361. PubMed ID: 31868223
[TBL] [Abstract][Full Text] [Related]
20. Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women.
De Sousa Mendes M; Hirt D; Urien S; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Benaboud S
Br J Clin Pharmacol; 2015 Nov; 80(5):1031-41. PubMed ID: 26011128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
